Vivus Wins Its First Fda Drug Approval

The FDA approved a drug to treat erectile dysfunction from Vivus that would compete against Viagra, Cialis and Levitra.

Topics:  fda   vivus   viagra   cialis   levitra   drug   
  • Instant pleasure: Vivus ED pill wins faster-acting 'on demand' label
    The FDA on Thursday approved a revised label for Vivus' erectile dysfunction pill Stendra. Auxilium, which won marketing rights to Stendra in a deal that could be worth as much as $300 million, can now market the drug for use 15 minutes before sex rather ...
    09/17/2014 - 1:00 pm | View Link
  • Vivus And Its Diet Pill Get A Needed Break, But Will This Make A Difference?
    After considerable anticipation, the FDA has finally eased restrictions on how the Vivus ... Sometimes, it’s not the better drug that wins, but the better detailed drug.”
    04/17/2013 - 3:48 am | View Link
  • Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
    Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ...
    07/17/2012 - 12:32 pm | View Link
  • Vivus Weight-Loss Pill Wins Backing of FDA Panel
    Advisers to the Food and Drug Administration voted 20-2 Wednesday that Qnexa’s benefits outweigh its risks at a meeting at agency headquarters in Silver Spring, Maryland. The FDA isn’t required to follow the panel’s recommendation. The agency is ...
    02/22/2012 - 4:41 am | View Link
  • CORRECTED-Vivus' weight-loss drug faces key U.S. test
    If Qnexa wins the FDA's green light, that could more than double. Analysts estimate Vivus' drug could take in nearly $689 million in sales by 2014, according to consensus forecast data from Thomson Reuters. It would be the second U.S. drug for the biotech ...
    07/15/2010 - 1:11 am | View Link
  • More
  • VCEL Stock Quote
    Updated stock quote for VCEL - including VCEL stock price today, earnings and estimates, stock charts, news, futures and other investing data.
    01/16/2017 - 7:31 pm | View Website
  • Today's Stock Market News and Analysis
    Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more.
    01/16/2017 - 2:01 pm | View Website
  • FiercePharma
    Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.
    01/11/2017 - 2:22 pm | View Website
  • Zacks Investment Research: Stock Research, Analysis ...
    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Gain free stock research access to stock picks, stock ...
    01/10/2017 - 10:15 pm | View Website
  • US Top News and Analysis – CNBC
    12 Hours Ago. Northman's Sven Henrich believes the bull market is on its last legs, and a recession is soon to follow.
    01/10/2017 - 11:10 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News